Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Markiewicz

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1996
[Similar risk of thrombosis complications in heterozygous carriers of Leiden mutation and in patients with idiopathic thromboembolic disease]K Lewandowski, Z Turowiecka, M Rozek, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Combined hemostatic defects in family members of symptomatic carriers of Leiden mutations of factor V]K Lewandowski, M Rozek, Z Turowiecka, et al.
Nucleic Acids Research|May 25, 1989
Effect of the sequence-dependent structure of the 17 bp AT spacer on the strength of consensuslike E.coli promoters in vivoT Lozinski, W T Markiewicz, T K Wyrzykiewicz, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|May 1, 1999
DNA sequencing with positive and negative errorsJ Błazewicz, P Formanowicz, M Kasprzak, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 1, 1996
[Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C]K L Lew Andowski, M Rozek, Z Turowiecka, et al.
Molecular Biosystems|December 6, 2016
Effect of small molecules on cell reprogrammingM Baranek, A Belter, M Z Naskręt-Barciszewska, et al.
Nucleic Acids Research|July 1, 1977
Nucleoside 3'-phosphotriesters as key intermediates for the oligoribonucleotide synthesis. IV. New method for removal of 2,2,2-trichloroethyl group and 31P NMR as a new tool for analysis of deblocking of internucleotide phosphate protecting groupsR W Adamiak, E Biala, Grześkowiak, et al.
Nucleosides & Nucleotides|August 26, 1998
Studies on synthesis and structure of O-beta-D-ribofuranosyl(1"-->2')ribonucleosides and oligonucleotidesW T Markiewicz, A Niewczyk, Z Gdaniec, et al.
Nucleic Acids Symposium Series|January 1, 1980
Further studies on oligoribonucleotide synthesisW T Markiewicz, E Biała, R W Adamiak, et al.
Nucleic Acids Research|September 15, 1997
A new method of synthesis of fluorescently labelled oligonucleotides and their application in DNA sequencingW T Markiewicz, G Gröger, R Rösch, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Polskie Archiwum Medycyny Wewnetrznej|October 1, 1996
[Similar risk of thrombosis complications in heterozygous carriers of Leiden mutation and in patients with idiopathic thromboembolic disease]K Lewandowski, Z Turowiecka, M Rozek, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 7, 1998
[Combined hemostatic defects in family members of symptomatic carriers of Leiden mutations of factor V]K Lewandowski, M Rozek, Z Turowiecka, et al.
Nucleic Acids Research|May 25, 1989
Effect of the sequence-dependent structure of the 17 bp AT spacer on the strength of consensuslike E.coli promoters in vivoT Lozinski, W T Markiewicz, T K Wyrzykiewicz, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|May 1, 1999
DNA sequencing with positive and negative errorsJ Błazewicz, P Formanowicz, M Kasprzak, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 1, 1996
[Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C]K L Lew Andowski, M Rozek, Z Turowiecka, et al.
Molecular Biosystems|December 6, 2016
Effect of small molecules on cell reprogrammingM Baranek, A Belter, M Z Naskręt-Barciszewska, et al.
Nucleic Acids Research|July 1, 1977
Nucleoside 3'-phosphotriesters as key intermediates for the oligoribonucleotide synthesis. IV. New method for removal of 2,2,2-trichloroethyl group and 31P NMR as a new tool for analysis of deblocking of internucleotide phosphate protecting groupsR W Adamiak, E Biala, Grześkowiak, et al.
Nucleosides & Nucleotides|August 26, 1998
Studies on synthesis and structure of O-beta-D-ribofuranosyl(1"-->2')ribonucleosides and oligonucleotidesW T Markiewicz, A Niewczyk, Z Gdaniec, et al.
Nucleic Acids Symposium Series|January 1, 1980
Further studies on oligoribonucleotide synthesisW T Markiewicz, E Biała, R W Adamiak, et al.
Nucleic Acids Research|September 15, 1997
A new method of synthesis of fluorescently labelled oligonucleotides and their application in DNA sequencingW T Markiewicz, G Gröger, R Rösch, et al.
Pageof 3